ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Takeda sells Japan’s non-core products portfolio to Teijin Pharma
April 02, 2021Takeda Pharmaceutical has completed the asset transfer linked to a portfolio of select non-core products in Japan to Teijin Pharma for $1.25bn (JPY133bn). -
Takeda to sell OTC and non-core assets to Orifarm for $670m
April 26, 2020Takeda Pharmaceutical has signed an agreement to sell around 110 of its non-core over-the-counter (OTC) and prescription pharmaceutical products to Danish pharmaceutical firm Orifarm Group for $670m.
Pharma Sources Insight January 2025
